67.16
price up icon0.51%   0.34
after-market After Hours: 67.16
loading
Hologic Inc stock is traded at $67.16, with a volume of 1.86M. It is up +0.51% in the last 24 hours and up +2.80% over the past month. Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$66.82
Open:
$66.35
24h Volume:
1.86M
Relative Volume:
0.61
Market Cap:
$14.97B
Revenue:
$4.03B
Net Income/Loss:
$556.70M
P/E Ratio:
28.34
EPS:
2.37
Net Cash Flow:
$970.10M
1W Performance:
+0.99%
1M Performance:
+2.80%
6M Performance:
-6.90%
1Y Performance:
-19.28%
1-Day Range:
Value
$65.35
$67.26
1-Week Range:
Value
$64.78
$67.52
52-Week Range:
Value
$51.90
$84.67

Hologic Inc Stock (HOLX) Company Profile

Name
Name
Hologic Inc
Name
Phone
(508) 263-2900
Name
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Name
Employee
7,063
Name
Twitter
@Hologic
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
HOLX's Discussions on Twitter

Compare HOLX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
HOLX
Hologic Inc
67.16 14.86B 4.03B 556.70M 970.10M 2.37
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
483.12 172.46B 9.15B 2.61B 1.99B 7.17
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
176.37 51.09B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
87.87 43.30B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
279.20 39.87B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
239.26 17.20B 2.90B 467.20M 306.90M 6.37

Hologic Inc Stock (HOLX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-09-25 Upgrade Citigroup Neutral → Buy
May-27-25 Reiterated Needham Hold
Mar-03-25 Downgrade Argus Buy → Hold
Feb-06-25 Downgrade Leerink Partners Outperform → Market Perform
Feb-03-25 Downgrade Needham Buy → Hold
Dec-13-24 Initiated Wolfe Research Peer Perform
Dec-10-24 Initiated Jefferies Hold
Dec-10-24 Reiterated Needham Buy
Oct-01-24 Downgrade Citigroup Buy → Neutral
Jun-27-24 Initiated Stephens Overweight
Apr-03-24 Upgrade Citigroup Neutral → Buy
Jul-14-23 Upgrade Needham Hold → Buy
Dec-07-22 Initiated RBC Capital Mkts Sector Perform
Oct-13-22 Initiated Mizuho Buy
Jul-20-22 Downgrade BofA Securities Buy → Neutral
Jul-20-22 Initiated UBS Neutral
Jul-18-22 Downgrade BTIG Research Buy → Neutral
Apr-25-22 Downgrade Wells Fargo Overweight → Equal Weight
Apr-04-22 Downgrade Evercore ISI Outperform → In-line
Dec-15-21 Downgrade Citigroup Buy → Neutral
Oct-15-21 Resumed Cowen Outperform
Oct-14-21 Initiated Redburn Neutral
Jul-06-21 Upgrade Evercore ISI In-line → Outperform
Nov-20-20 Downgrade Needham Buy → Hold
Nov-05-20 Reiterated Needham Buy
Jun-30-20 Upgrade Cowen Market Perform → Outperform
Jun-03-20 Upgrade Raymond James Mkt Perform → Outperform
Apr-30-20 Reiterated Needham Buy
Apr-30-20 Upgrade SVB Leerink Mkt Perform → Outperform
Apr-07-20 Upgrade Wells Fargo Equal Weight → Overweight
Mar-27-20 Upgrade Morgan Stanley Underweight → Equal-Weight
Jan-13-20 Reiterated Needham Buy
Jan-08-20 Initiated Wells Fargo Equal Weight
Jan-07-20 Initiated Citigroup Buy
Jan-02-20 Downgrade Evercore ISI Outperform → In-line
Sep-26-19 Upgrade BofA/Merrill Neutral → Buy
Aug-01-19 Reiterated Needham Buy
May-02-19 Reiterated Needham Buy
Jan-31-19 Reiterated Needham Buy
Jan-02-19 Downgrade Morgan Stanley Equal-Weight → Underweight
Oct-09-18 Initiated UBS Neutral
Sep-13-18 Downgrade BofA/Merrill Buy → Neutral
View All

Hologic Inc Stock (HOLX) Latest News

pulisher
02:50 AM

What makes Hologic Inc. stock price move sharplyFree Stock Alerts For Every Investor - jammulinksnews.com

02:50 AM
pulisher
06:57 AM

What are analysts’ price targets for Hologic Inc. in the next 12 monthsReal Time Ideas With Low Risk - jammulinksnews.com

06:57 AM
pulisher
02:52 AM

Stock Analysis | Hologic OutlookA Closer Look at Mixed Signals and Market Trends - AInvest

02:52 AM
pulisher
12:10 PM

Hologic 2025 Q3 Earnings Beats Expectations as Net Income Grows 0.2% - AInvest

12:10 PM
pulisher
Jul 31, 2025

Hologic, Inc. shares fall 1.53% after-hours following Morgan Stanley's price target adjustment to $69. - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

Mizuho raises Hologic stock price target to $75 on strong quarterly results - Investing.com Canada

Jul 31, 2025
pulisher
Jul 31, 2025

Hologic (HOLX) Sees Updated Analyst Ratings and Price Targets | - GuruFocus

Jul 31, 2025
pulisher
Jul 31, 2025

Hologic Stock Falls Despite Q3 Earnings and Revenue Beat, Margins Down - Yahoo Finance

Jul 31, 2025
pulisher
Jul 31, 2025

Hologic revenue increases 1.2% to USD 1,023.8M in Q2 2025 - Medical Buyer

Jul 31, 2025
pulisher
Jul 31, 2025

HOLOGIC INC SEC 10-Q Report - TradingView

Jul 31, 2025
pulisher
Jul 31, 2025

Hologic Inc (HOLX) Q3 2025 Earnings Call Highlights: Surpassing Expectations Amidst Challenges By GuruFocus - Investing.com Canada

Jul 31, 2025
pulisher
Jul 31, 2025

Hologic (HOLX) Q3 Revenue Beats 1% - The Globe and Mail

Jul 31, 2025
pulisher
Jul 31, 2025

Hologic Inc (HOLX) Q3 2025 Earnings Call Highlights: Surpassing Expectations Amidst Challenges - Yahoo.co

Jul 31, 2025
pulisher
Jul 31, 2025

What markets is Hologic Inc. expanding into Is KMDA stock a good long term investment optionAdvanced Screener Ideas For Fast Growth - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Hologic Announces Financial Results for Third Quarter of Fiscal 2025 - BioSpace

Jul 31, 2025
pulisher
Jul 31, 2025

Hologic Reports Strong Q3 2025 Earnings, Exceeds Guidance - TipRanks

Jul 31, 2025
pulisher
Jul 30, 2025

Hologic Inc Q3 Profit Increases, Beats Estimates - Nasdaq

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic targets mid-single-digit organic revenue growth in 2026 as Breast Health rebounds and tariff mitigation advances - MSN

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic's Q3 Earnings Beat: A Strategic Turnaround in the Making? - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:HOLX) - Seeking Alpha

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic raises annual profit forecast on diagnostic and surgical demand - 1470 & 100.3 WMBD

Jul 30, 2025
pulisher
Jul 30, 2025

Earnings call transcript: Hologic Q3 2025 beats earnings estimates, stock dips By Investing.com - Investing.com Nigeria

Jul 30, 2025
pulisher
Jul 30, 2025

Earnings call transcript: Hologic Q3 2025 beats earnings estimates, stock dips - Investing.com Australia

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic Q3 2025 Earnings Call Transcript - MarketBeat

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic's Strategic Shift: Capitalizing on Breast Health and Surgical Growth Amid Diagnostics Downturn - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Compared to Estimates, Hologic (HOLX) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic Q2 Revenue Beats Estimates, Stock Surges - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic: Fiscal Q3 Earnings Snapshot - NewsTimes

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic Inc (HOLX) Q3 Earnings: Non-GAAP EPS of $1.08 Beats Estimates, Revenue Surpasses $1.02 Billion - GuruFocus

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic Q3 2025 slides: modest growth amid mixed segment performance By Investing.com - Investing.com South Africa

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic Q3 2025 slides: modest growth amid mixed segment performance - Investing.com Australia

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic earnings beat by $0.03, revenue topped estimates - Investing.com Australia

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic shares jump 7% as Q3 earnings and guidance top expectations - Investing.com India

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic Reports Q3 Earnings: EPS Beats Expectations, Revenue Tops Estimates - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic’s (NASDAQ:HOLX) Q2 Sales Beat Estimates, Stock Soars - TradingView

Jul 30, 2025
pulisher
Jul 30, 2025

Breast Biopsy Marker Market Set to Hit US$ 1.4 Billion by 2032 | Key - openPR.com

Jul 30, 2025
pulisher
Jul 30, 2025

Hologic Focuses on Breast Health Turnaround This Year: Can It Deliver? - MSN

Jul 30, 2025
pulisher
Jul 30, 2025

U.S., Europe, and Asia Pacific Molecular Diagnostics Market - openPR.com

Jul 30, 2025
pulisher
Jul 30, 2025

Does Hologic’s (HOLX) Debt Refinancing Signal a Shift in Financial Strategy? - simplywall.st

Jul 30, 2025
pulisher
Jul 29, 2025

Gynecological Devices Market Set to Witness Significant Growth - openPR.com

Jul 29, 2025
pulisher
Jul 29, 2025

Cancer Biopsy Market Set to Witness Significant Growth - openPR.com

Jul 29, 2025
pulisher
Jul 29, 2025

Short Term Charts Align With Long Term Uptrend in Hologic Inc.Smart Trade Plans With Risk Protection Explained - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Hologic Inc. Quarterly Earnings Preview: Flat Revenue and Analyst ExpectationsNews and Statistics - IndexBox

Jul 29, 2025
pulisher
Jul 29, 2025

Herpes Markers Testing Market Outlook 2024 to 2034: Growth - openPR.com

Jul 29, 2025
pulisher
Jul 29, 2025

Human Papilloma Virus Testing Market Research Report - GlobeNewswire

Jul 29, 2025
pulisher
Jul 28, 2025

Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

Hologic Inc. stock outperforms competitors despite losses on the day - MarketWatch

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy Hologic Inc. stockSmart Portfolio Growth Plan That Work - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit - AboutLawsuits.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Hologic Inc.Exceptional earning trajectories - jammulinksnews.com

Jul 28, 2025

Hologic Inc Stock (HOLX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Hologic Inc Stock (HOLX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Mitchell Essex D
Chief Operating Officer
Dec 04 '24
Option Exercise
62.60
22,902
1,433,659
52,813
Mitchell Essex D
Chief Operating Officer
Dec 04 '24
Sale
76.34
24,856
1,897,482
27,957
medical_instruments_supplies COO
$70.87
price up icon 0.25%
medical_instruments_supplies WST
$239.26
price up icon 0.00%
$71.73
price up icon 0.52%
medical_instruments_supplies BAX
$21.96
price up icon 0.92%
$136.52
price up icon 5.82%
Cap:     |  Volume (24h):